2 ASX shares in a sector ready for a massive comeback

This industry has suffered as interest rates have risen. But this just means there are stocks with compelling discounts at the moment.

| More on:
a man in a business suit and carrying a laptop stands smiling with hand in pocket outside a large office building in a city environment.

Imge source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Even before interest rates rose 125 basis points over the last couple of months, the fear of rate hikes had already infected many sectors.

Perhaps one sector that is the most directly impacted is real estate.

Interest rate rises increase mortgage repayments, which dampen demand and property prices.

Now one of the hottest real estate markets in the world, Sydney, is set for a 20% fall in house prices.

Not only this, the COVID-19 pandemic has meant commercial real estate has also taken a beating as many workers stick to using their homes as offices.

All this has meant that ASX shares in real estate investment trusts (REITs) have taken a brutal hit in 2022.

In fact, the S&P/ASX 200 A-REIT (ASX: XPJ) has dropped almost 23% since the start of the year.

REITs set for a stunning comeback

Inflation is still running rampant and the US Federal Reserve is set to deliver super-sized rate increases in the coming months. 

The Reserve Bank of Australia is sure to follow, in order to fix Australia's own inflation and not devalue the local dollar excessively against the greenback.

Despite this prospect, Wilsons head of investment strategy David Cassidy feels real estate shares could turn it around soon.

"We tend to believe the REIT sector's underperformance should be coming to an end given that bond yields have started to stabilise, market focus will shift to the defensive aspects of REITs, [and] valuations are generally supportive."

He said in a Wilsons memo that high inflation could ironically benefit landlords, if rents rise faster than financing and labour costs.

"This would result in greater top-line revenue, which may in turn be reflected in higher cash flows."

Cassidy warned, though, that REITs with genuine pricing power are the ones providing space in "in-demand, fast-growing sectors, such as distribution warehouses, data centres, and life science facilities".

"These specialty sectors will likely exhibit the most significant pricing power, which will still give them an attractive growth profile relative to traditional sectors like office and retail," he said.

"We believe the logistics sector offers the best prospects for rental growth, consistent with consensus expectations."

Two ASX shares with excellent long-term prospects 

Cassidy named Goodman Group (ASX: GMG) and Healthco Healthcare and Wellness REIT (ASX: HCW) as ASX shares his team is focused on.

Warehouse and fulfilment centre provider Goodman is banking on the long-term transition to the digital economy.

"Continued growth in e-commerce drives strong demand for modern, well-located, urban infill logistics sites," said Cassidy.

"Supply of such sites is relatively scarce and barriers to entry are high."

A 30% cooling of the Goodman share price year-to-date has made it more appetising for buyers too.

"In our view, Goodman's valuation is currently attractive with the group trading at a forward price-to-earnings multiple of ~20.6x, which is favourable in the context of management's guided +23% EPS growth for FY22 and a mid-double-digit EPS growth expected over the medium-term."

The Healthco REIT is a landlord for sites like private hospitals, gyms, childcare centres, aged-care facilities, and life sciences research facilities.

Those clients generally sign long leases — on average 10 years — and pay for their own ongoing property expenses.

Cassidy likes this tenant profile through an economic downturn.

"Healthco maintains a defensive earnings profile through the cycle given tenant demand is consistent and non-discretionary in nature, and mostly government-supported."

Healthco shares have lost around 35% so far in 2022, making for a mouth-watering entry point at the moment.

"HCW currently trades at a compelling ~25% discount to its $647 million portfolio valuation and NTA [net tangible assets] per unit of $2.02 as of 30 June 2022, and offers a forward dividend yield of 5.6%."

Motley Fool contributor Tony Yoo has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A wad of $100 bills of Australian currency lies stashed in a bird's nest.
Broker Notes

Up 40% in a year, why Macquarie expects this ASX 200 dividend stock to keep outperforming in 2026

Macquarie forecasts more outperformance from this fast-rising ASX 200 dividend stock.

Read more »

A man wearing glasses and a white t-shirt pumps his fists in the air looking excited and happy about the rising OBX share price
Broker Notes

These ASX 200 shares could rise 30% to 40%

Looking for big returns? Bell Potter thinks these shares could be the ones to buy.

Read more »

Man standing on the roof rack of a van next to boxes and gear
Broker Notes

Broker tips 30% upside for this ASX 200 stock

This ASX 200 stock could now be a buy-low option.

Read more »

Broker looking at the share price.
Broker Notes

Broker ratings on 6 ASX shares about to join the ASX 200

These 6 companies will enter the ASX 200 in the December quarter rebalance. Should you buy them?

Read more »

A happy elderly woman smiles and cheers as she looks at good investment news on her laptop.
Broker Notes

Macquarie forecasts this $3.4 billon ASX healthcare share is set surge 33%

Macquarie tips material outperformance from this ASX healthcare share in 2026.

Read more »

Man looking at digital holograms of graphs, charts, and data.
Broker Notes

3 reasons this ASX 300 tech stock is forecast to leap 83% in 2026

A leading broker expects some outsized returns from this ASX 300 tech share. Let’s see why.

Read more »

gold share price represented by speeding golden bullet
Broker Notes

Why this surging ASX All Ords gold stock is tipped to rocket another 233%

A leading broker expects outsized gains from this ASX All Ords gold stock. But not without risk.

Read more »

A blockchain investor sits at his desk with a laptop computer open and a phone checking information from a booklet in a home office setting.
Broker Notes

3 buy-rated ASX 300 shares at 52-week lows

They've fallen far over the past 12 months but have buy ratings from the experts.

Read more »